Study guide

9.6 NIOSH Occupational Exposure Banding

CIH Certified Industrial Hygienist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The CIH Exam and How to Use This Guide

1.1 CIH Exam Format, Scoring, and Test-Day Logistics 1.2 Eligibility, Application Windows, Fees, and Certification Maintenance 1.3 The BGC Blueprint, Subject Areas, and a Calculation-First Study Plan

2 Chapter 2: Basic Science & Calculations

2.1 Gas Laws and Vapor Calculations 2.2 Unit Conversions: ppm, mg/m³, and Standard Temperature/Pressure 2.3 Fluid Mechanics and Airflow Fundamentals

3 Chapter 3: Air Sampling & Instrumentation

3.1 Active and Passive Air Sampling Strategies 3.2 Particulate and Aerosol Sampling 3.3 Direct-Reading Instruments and Calibration

4 Chapter 4: Analytical Chemistry & Lab Methods

4.1 Gas Chromatography and Mass Spectrometry 4.2 High-Performance Liquid Chromatography and Ion Chromatography 4.3 Spectroscopy and Elemental Analysis 4.4 Gravimetric, Microscopy, and Wet Chemical Methods 4.5 Laboratory Quality Assurance, Chain of Custody, and Desorption Efficiency

5 Chapter 5: Biostatistics & Epidemiology

5.1 Lognormal Distributions and Exposure Data Statistics 5.2 Upper Confidence Limits (UCL95) and Compliance Decision Rules 5.3 Epidemiological Study Designs and Measures of Association 5.4 Sampling Strategy: Sample Size, Power, and Worker Selection

6 Chapter 6: Toxicology & Biological Monitoring

6.1 Dose-Response Relationships and Points of Departure 6.2 Toxicokinetics: Absorption, Distribution, Metabolism, and Elimination 6.3 Aerosol Deposition, Clearance, and Respiratory Tract Dosimetry 6.4 Hepatic, Renal, Neurologic, and Hematologic Target Organ Toxicity 6.5 Pulmonary Toxicology, Carcinogenicity, and Reproductive Hazards 6.6 OEL Frameworks, Classifications, and Excursion Limits 6.7 Chemical Mixtures and Extended Work-Shift OEL Adjustments 6.8 Biological Exposure Indices (BEIs) and Biomonitoring

7 Chapter 7: Biohazards & Indoor Environmental Quality

7.1 Mold, Fungi, and Microbial Contaminants 7.2 Infectious Agents, Bloodborne Pathogens, and Biosafety Levels 7.3 Indoor Environmental Quality (IEQ) Investigations 7.4 Sanitation, Potable Water, and Personal Hygiene Programs

8 Chapter 8: Community Exposure & Environmental Health

8.1 Clean Air Act Framework, NAAQS, and New Source Review 8.2 Hazardous Air Pollutants, CEMS, and EPA Reference Methods 8.3 Atmospheric Stability, Lapse Rates, and Plume Morphology 8.4 Gaussian Plume Modeling, Plume Rise, and Environmental Fate 8.5 HAZWOPER Scope, Mandates, and Training Tiers 8.6 Protection Levels, Site Zoning, Incident Command, and Decontamination 8.7 Water Pollution, Hazardous Waste, and Community Right-to-Know

9 Chapter 9: Health Risk Analysis & Hazard Communication

9.1 GHS Hazard Classification: Health and Physical Hazard Criteria 9.2 GHS Labels, Safety Data Sheets, and Trade Secret Rules 9.3 The AIHA Exposure Assessment Strategy and Similar Exposure Groups 9.4 Qualitative Exposure Profiling and the AIHA Risk Matrix 9.5 Quantitative Health Risk Characterization: HQ, HI, and ELCR 9.6 NIOSH Occupational Exposure Banding 9.7 Risk Communication and Reporting to Affected Parties

10 Chapter 10: Industrial Ventilation Principles & LEV Design

10.1 Elimination, Substitution, Isolation, Containment, and Process Change 10.2 LEV Hood Taxonomy and Capture Velocity Selection 10.3 Hood Airflow Equations, Entry Losses, and Hood Static Pressure 10.4 Particulate Transport Aerodynamics and Duct Sizing 10.5 Duct Friction, Fitting Losses, and System Balancing 10.6 Fan Categories and Pressure Dynamics Across the Fan 10.7 System Curves, the Fan Laws, and Density Corrections

11 Chapter 11: General Ventilation, Air Cleaning & Diagnostics

11.1 Dilution Ventilation Principles and Steady-State Modeling 11.2 Transient Purging and Air Distribution Geometry 11.3 Particulate Air Cleaning: Cyclones, Baghouses, Scrubbers, and ESPs 11.4 Gaseous Emission Control and Air Cleaner Selection 11.5 Ventilation System Troubleshooting and Testing

12 Chapter 12: Noise Measurement & Hearing Conservation

12.1 Acoustic Physics and Decibel Mathematics 12.2 Sound Propagation, Octave Bands, and Frequency Weighting 12.3 Noise Dose Metrics and OSHA versus ACGIH Criteria 12.4 Exchange Rates, Extended Shifts, and Dosimetry Field Protocols 12.5 Engineering Noise Controls and Hearing Protector Attenuation 12.6 Hearing Conservation Programs and Standard Threshold Shifts 12.7 Hand-Arm and Whole-Body Vibration

13 Chapter 13: Thermal Stress Assessment & Control

13.1 Wet Bulb Globe Temperature (WBGT) and Heat Stress Indices 13.2 Heat-Related Disorders, Acclimatization, and Work/Rest Regimens 13.3 Cold Stress Evaluation and Wind Chill

14 Chapter 14: Ionizing Radiation Protection

14.1 Ionizing Radiation Physics and Radioactive Decay Kinetics 14.2 Radiation Units, Radiobiology, and Health Effects 14.3 ALARA, Stay-Time, and the Inverse Square Law 14.4 Shielding Physics, Material Selection, and Gamma Constants 14.5 Radiation Detection Instruments and Spectrometry 14.6 Personnel Dosimetry, Dose Limits, and Contamination Surveys

15 Chapter 15: Non-Ionizing Radiation & Laser Safety

15.1 The Non-Ionizing Spectrum and Static/ELF Field Exposures 15.2 Radiofrequency and Microwave Exposure: SAR, Standards, and Surveys 15.3 Ultraviolet, Visible, and Infrared Radiation Hazards 15.4 Laser Safety Classifications and Optical Density Calculations 15.5 Illumination, Lighting Design, and Visual Performance

16 Chapter 16: Non-Engineering Controls & Personal Protective Equipment

16.1 Respiratory Protection Programs and Assigned Protection Factors 16.2 Maximum Use Concentration, Oxygen Deficiency, and Breathing Air 16.3 Particulate Filters, Sorbent Cartridges, and Change Schedules 16.4 Respirator Fit Testing Protocols 16.5 Chemical Protective Clothing and Dermal Exposure Control

17 Chapter 17: Ergonomics & Workstation Design

17.1 Soft-Tissue Biomechanics and WMSD Pathophysiology 17.2 Ergonomic Risk Factors and Their Interaction Effects 17.3 The Revised NIOSH Lifting Equation 17.4 RULA, REBA, the Strain Index, and the ACGIH HAL TLV 17.5 Anthropometry and Workstation Geometry 17.6 VDT Workstations, Hand Tool Design, and Administrative Ergonomics

18 Chapter 18: Work Environments & Industrial Processes

18.1 Welding Fume Emissions, Metal Fume Fever, and Cr(VI)/Manganese Toxicology 18.2 Foundry Operations and Hot Work Fire Prevention 18.3 Vapor Degreasing, Pickling, Electroplating, and Cyanide Baths 18.4 Spray Coatings, Isocyanates, and Semiconductor Manufacturing 18.5 Confined Spaces and High-Hazard Industrial Operations 18.6 Asbestos, Lead, and Silica: Regulated Substance Programs 18.7 Abrasive Blasting and Surface Preparation

19 Chapter 19: IH Program Management & Professional Ethics

19.1 The BGC Code of Ethics: Canons and Enforcement 19.2 Professional Liability, Standard of Care, and Expert Testimony 19.3 Occupational Health & Safety Management Systems (ISO 45001, ANSI Z10) 19.4 Exposure Records Access and Medical Surveillance 19.5 OSHA Injury and Illness Recordkeeping and Enforcement

9.6 NIOSH Occupational Exposure Banding

Key Takeaways Explain This Topic AI

Occupational exposure banding assigns a chemical to one of five potency bands (A through E) when no OEL exists, using toxicological data rather than a derived numerical limit.

Band A corresponds to the lowest potency with target airborne concentrations above 10 ppm or 1 mg/m³, and Band E to the highest with targets below 0.01 ppm or 0.01 mg/m³.

The NIOSH process has three tiers of increasing data requirement and rigour: Tier 1 uses GHS classification and hazard statements, Tier 2 uses available toxicological data against defined criteria, and Tier 3 requires expert judgement on the full data set.

A band is a control target, not a legal limit: it drives the selection of a control strategy under control banding, and is superseded whenever an authoritative OEL exists.

Last updated: August 2026

NIOSH Occupational Exposure Banding

Quantitative risk characterization requires a reference dose or slope factor. Thousands of workplace chemicals have neither, and no OEL either — which is the gap occupational exposure banding was designed to fill.

1. The NIOSH Occupational Exposure Banding (OEB) Process

To address the thousands of workplace chemicals lacking formal OELs, NIOSH developed the Occupational Exposure Banding (OEB) framework (NIOSH Publication No. 2019-132). Occupational exposure banding is a systematic, evidence-based process that assigns a chemical to one of five exposure concentration bands based on its toxicological potency and health hazard profile. +-------------------------------------------------------------------------+

  • | THE 3-TIERED NIOSH EXPOSURE BANDING PROCESS |
  • +-------------------------------------------------------------------------+
  • | |
  • | [ TIER 1: AUTOMATED / SCREENING ] |
  • | - User Input: GHS Hazard Codes (H-phrases) & Categories |
  • | - Tool: Automated NIOSH OEB Electronic Algorithm |
  • | - Target User: General H&S personnel, quick initial screening |
  • | | |
  • | v |
  • | [ TIER 2: SEMI-QUANTITATIVE / SECONDARY DATA ] |
  • | - User Input: Secondary peer-reviewed databases (ECHA, RTECS, SIDS) |
  • | - Evaluates 9 discrete toxicological health endpoints |
  • | - Applies determinative algorithms and weight-of-evidence rules |
  • | - Target User: Industrial Hygienists, Occupational Health Specialists |
  • | | |
  • | v |
  • | [ TIER 3: EXPERT TOXICOLOGICAL REVIEW ] |
  • | - User Input: Primary experimental bioassays, raw laboratory studies |
  • | - Evaluates pharmacokinetic models, mechanistic mode-of-action data |
  • | - Target User: Board-Certified Toxicologists, Senior IH Specialists |
  • +-------------------------------------------------------------------------+
  • The 9 Health Endpoints Evaluated in Tier 2 OEB
  • Carcinogenicity
  • Germ Cell Mutagenicity
  • Reproductive and Developmental Toxicity
  • Respiratory Sensitization
  • Skin Sensitization
  • Specific Target Organ Toxicity — Repeated Exposure (STOT-RE)
  • Specific Target Organ Toxicity — Single Exposure (STOT-SE)
  • Acute Toxicity (Oral, Dermal, Inhalation)
  • Skin Corrosion / Irritation and Serious Eye Damage / Irritation

The "Most Protective Band" Decision Rule: In both Tier 1 and Tier 2 evaluations, each endpoint is assigned an individual band (Band A through E). The overall, final chemical band assignment is governed by the most stringent (lowest concentration) band among all evaluated endpoints.

2. The 5 NIOSH Occupational Exposure Bands (Bands A to E)

The NIOSH OEB process assigns substances into five airborne concentration ranges, differentiated by physical state (particulates vs. gases/vapors):

NIOSH Exposure Band Target Airborne Concentration: Particulates (Dusts/Mists) Target Airborne Concentration: Gases and Vapors Health Hazard Severity & Toxicological Characteristics

Band A > 10 mg/m³ > 100 ppm Low Toxicity / Nuisance: Mild, reversible sensory irritation; non-hazardous particulate matter.

Band B > 1 to 10 mg/m³ > 10 to 100 ppm Moderate Toxicity: Reversible skin/eye irritation; transient central nervous system depression (STOT-SE 3).

Band C > 0.1 to 1 mg/m³ > 1 to 10 ppm Severe Irritation / Systemic Toxicity: Severe eye irritation; moderate organ toxicity; low-potency skin sensitizers.

Band D > 0.01 to 0.1 mg/m³ > 0.1 to 1 ppm High Systemic Toxicity: Skin corrosion; STOT-RE Category 2; potent dermal sensitizers; high acute lethality.

Band E ≤ 0.01 mg/m³ ≤ 0.1 ppm (or < 0.001 ppm) Extreme Toxicity / Carcinogenicity: Known/presumed human carcinogens (Cat 1A/1B), mutagens, reproductive toxicants, potent respiratory sensitizers. +-------------------------------------------------------------------------+

  • | NIOSH OCCUPATIONAL EXPOSURE BANDS |
  • +-------------------------------------------------------------------------+
  • | Toxicity Severity Airborne Limit |
  • | +------------------------------------------------+ +----------------+ |
  • | | BAND E: Carcinogens, Mutagens, Repro, Resp Sens | | <=0.01 mg/m³ | |
  • | | BAND D: Skin Corrosive, High Organ Tox, STOT-RE | | 0.01-0.1 mg/m³ | |
  • | | BAND C: Severe Eye Irritant, Moderate Organ Tox | | 0.1-1.0 mg/m³ | |
  • | | BAND B: Reversible Irritants, STOT-SE Cat 3 | | 1.0-10 mg/m³ | |
  • | | BAND A: Low Toxicity, Nuisance Particulates | | > 10 mg/m³ | |
  • | +------------------------------------------------+ +----------------+ |
  • | (Least Stringent Band A ===============> Most Stringent Band E) |
  • +-------------------------------------------------------------------------+
  • Control Banding Engineering Linkage

Assigning an OEB provides immediate guidance for engineering control selection:

Band A: General dilution ventilation, good housekeeping.

Band B: Standard local exhaust ventilation (LEV), dedicated capture hoods.

Band C: Enclosed process equipment, local exhaust with high capture efficiency.

Band D: High-containment engineering (glovebags, vented enclosures, automated transfer).

Band E: Full containment isolators, negative-pressure gloveboxes, robotics, zero-emission seals.

  • 3. Worked Step-by-Step Risk Characterization Examples
  • Worked Example 8.3.1: Multi-Chemical Mixture Hazard Index (HI) and Target Organ Segregation

Problem: Workers in a fiberglass parts fabrication shop are exposed to airborne vapors of three volatile organic compounds during resin layup. Personal 8-hour air sampling and toxicological reference benchmarks yield the following data:

Methyl Ethyl Ketone (MEK): Measured concentration C1 = 150 mg/m³; Chronic Inhalation RfC1 = 5.0 mg/m³; Critical target organ: Upper Respiratory Tract & Eye Irritation.

Toluene: Measured concentration C2 = 1.2 mg/m³; Chronic Inhalation RfC2 = 5.0 mg/m³; Critical target organ: Central Nervous System (CNS).

Xylene (mixed isomers): Measured concentration C3 = 0.40 mg/m³; Chronic Inhalation RfC3 = 0.10 mg/m³; Critical target organ: Central Nervous System (CNS).

Calculate the individual Hazard Quotient (HQ) for each solvent.

Calculate the gross cumulative Hazard Index (HIgross) for the total mixture.

Perform target organ segregation and determine whether any specific target organ is at unacceptable non-cancer health risk.

Solution Steps:

Calculate Individual Hazard Quotients (HQ = C / RfC): H Q MEK = C 1 R f C 1 = 150 mg/m 3 5.0 mg/m 3 = 30.0 HQ_{\text{MEK}} = \frac{C_1}{RfC_1} = \frac{150\,\text{mg/m}^3}{5.0\,\text{mg/m}^3} = 30.0 H Q MEK ​ = R f C 1 ​ C 1 ​ ​ = 5.0 mg/m 3 150 mg/m 3 ​ = 30.0 H Q Toluene = C 2 R f C 2 = 1.2 mg/m 3 5.0 mg/m 3 = 0.24 HQ_{\text{Toluene}} = \frac{C_2}{RfC_2} = \frac{1.2\,\text{mg/m}^3}{5.0\,\text{mg/m}^3} = 0.24 H Q Toluene ​ = R f C 2 ​ C 2 ​ ​ = 5.0 mg/m 3 1.2 mg/m 3 ​ = 0.24 H Q Xylene = C 3 R f C 3 = 0.40 mg/m 3 0.10 mg/m 3 = 4.0 HQ_{\text{Xylene}} = \frac{C_3}{RfC_3} = \frac{0.40\,\text{mg/m}^3}{0.10\,\text{mg/m}^3} = 4.0 H Q Xylene ​ = R f C 3 ​ C 3 ​ ​ = 0.10 mg/m 3 0.40 mg/m 3 ​ = 4.0

Calculate Gross Mixture Hazard Index (HIgross): H I g r o s s = H Q MEK + H Q Toluene + H Q Xylene = 30.0 + 0.24 + 4.0 = 34.24 HI_{gross} = HQ_{\text{MEK}} + HQ_{\text{Toluene}} + HQ_{\text{Xylene}} = 30.0 + 0.24 + 4.0 = \mathbf{34.24} H I g ross ​ = H Q MEK ​ + H Q Toluene ​ + H Q Xylene ​ = 30.0 + 0.24 + 4.0 = 34.24

Because HIgross = 34.24 > 1.0, the gross mixture is unacceptable. We must perform target organ segregation.

Segregate by Critical Toxicological Target Organ:

Respiratory Tract / Ocular Irritation Index: H I Respiratory = H Q MEK = 30.0 ( 30.0 > 1.0 ⟹ Unacceptable ) HI_{\text{Respiratory}} = HQ_{\text{MEK}} = \mathbf{30.0} \quad (30.0 > 1.0 \implies \text{Unacceptable}) H I Respiratory ​ = H Q MEK ​ = 30.0 ( 30.0 > 1.0 ⟹ Unacceptable )

Central Nervous System (CNS Neurotoxicity) Index: H I CNS = H Q Toluene + H Q Xylene = 0.24 + 4.0 = 4.24 ( 4.24 > 1.0 ⟹ Unacceptable ) HI_{\text{CNS}} = HQ_{\text{Toluene}} + HQ_{\text{Xylene}} = 0.24 + 4.0 = \mathbf{4.24} \quad (4.24 > 1.0 \implies \text{Unacceptable}) H I CNS ​ = H Q Toluene ​ + H Q Xylene ​ = 0.24 + 4.0 = 4.24 ( 4.24 > 1.0 ⟹ Unacceptable )

Result: Both segregated target organs exhibit unacceptable risk: HIRespiratory = 30.0 and HICNS = 4.24 . Engineering controls must be installed to reduce both MEK and xylene airborne concentrations below their respective RfC levels.

Worked Example 8.3.2: Inhalation Lifetime Excess Cancer Risk (ELCR) Calculation

Problem: An occupational cohort in a chemical plant is exposed to airborne 1,3-butadiene (a confirmed human leukemogen). Industrial hygiene monitoring establishes a continuous shift air concentration of 0.050 mg/m³ (50 µg/m³).

Exposure parameters:

  • Worker inhalation rate: IR = 10 m³/shift (8-hour workday)
  • Exposure frequency: EF = 250 days/year
  • Exposure duration: ED = 25 years
  • Worker body weight: BW = 70.0 kg
  • EPA Oral Cancer Slope Factor for 1,3-butadiene: CSF = 0.60 (mg/kg/day)⁻¹
  • Lifetime averaging time: ATc = 70 years × 365 days/year = 25,550 days

Calculate the Lifetime Average Daily Dose (LADD) in mg/kg/day.

Calculate the Excess Lifetime Cancer Risk (ELCR).

Interpret the calculated risk against the regulatory de minimis benchmark (10⁻⁶) and upper action threshold (10⁻⁴).

Solution Steps:

Calculate the Lifetime Average Daily Dose (LADD): Daily Intake per Shift = C × I R = 0.050 mg/m 3 × 10 m 3 = 0.50 mg/day \text{Daily Intake per Shift} = C \times IR = 0.050\,\text{mg/m}^3 \times 10\,\text{m}^3 = 0.50\,\text{mg/day} Daily Intake per Shift = C × I R = 0.050 mg/m 3 × 10 m 3 = 0.50 mg/day L A D D = Daily Intake × E F × E D B W × A T c LADD = \frac{\text{Daily Intake} \times EF \times ED}{BW \times AT_c} L A DD = B W × A T c ​ Daily Intake × EF × E D ​ L A D D = 0.50 mg/day × 250 days/year × 25 years 70.0 kg × 25 , 550 days LADD = \frac{0.50\,\text{mg/day} \times 250\,\text{days/year} \times 25\,\text{years}}{70.0\,\text{kg} \times 25,550\,\text{days}} L A DD = 70.0 kg × 25 , 550 days 0.50 mg/day × 250 days/year × 25 years ​ L A D D = 3 , 125 mg 1 , 788 , 500 kg ⋅ days = 1.7473 × 10 − 3 mg/kg/day LADD = \frac{3,125\,\text{mg}}{1,788,500\,\text{kg}\cdot\text{days}} = 1.7473 \times 10^{-3}\,\text{mg/kg/day} L A DD = 1 , 788 , 500 kg ⋅ days 3 , 125 mg ​ = 1.7473 × 1 0 − 3 mg/kg/day

Calculate the Excess Lifetime Cancer Risk (ELCR): ELCR = L A D D × C S F = ( 1.7473 × 10 − 3 mg/kg/day ) × 0.60 ( mg/kg/day ) − 1 \text{ELCR} = LADD \times CSF = (1.7473 \times 10^{-3}\,\text{mg/kg/day}) \times 0.60\,(\text{mg/kg/day})^{-1} ELCR = L A DD × CSF = ( 1.7473 × 1 0 − 3 mg/kg/day ) × 0.60 ( mg/kg/day ) − 1 ELCR = 1.048 × 10 − 3 ≈ 1.05 × 10 − 3 \mathbf{\text{ELCR} = 1.048 \times 10^{-3} \approx 1.05 \times 10^{-3}} ELCR = 1.048 × 1 0 − 3 ≈ 1.05 × 1 0 − 3

Risk Interpretation:

The calculated excess cancer risk is 1.05 × 10⁻³ (approximately 1 excess cancer case per 954 exposed workers ).

This risk exceeds the EPA de minimis benchmark (10⁻⁶, 1 in 1,000,000) by a factor of over 1,000×, and exceeds the OSHA significant risk threshold (10⁻⁴, 1 in 10,000) by a factor of > 10×.

Conclusion: This represents a critical, unacceptable carcinogenic risk requiring immediate engineering isolation, closed-loop process transfer, and mandatory supplied-air respiratory protection.

Worked Example 8.3.3: NIOSH Tier 1 and Tier 2 Exposure Band Assignment for an Unregulated Chemical Intermediate

Problem: A specialty chemical synthesis laboratory develops a novel acrylate monomer lacking any published OSHA PEL or ACGIH TLV. GHS-compliant testing and secondary toxicological dossiers reveal:

Inhalation Acute Toxicity: LC50 = 4.5 mg/L (vapor, rat 4-hr) → GHS Category 3 ( H331: Toxic if inhaled ).

Skin Sensitization: Positive in LLNA (EC3 value = 0.8%) → GHS Category 1A ( H317: May cause an allergic skin reaction ).

Respiratory Sensitization: Clinical reports of severe occupational asthma in synthesis technicians → GHS Category 1A ( H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled ).

Eye Irritation: Severe reversible conjunctival irritation → GHS Category 2A ( H319: Causes serious eye irritation ).

Determine the individual NIOSH exposure band for each of the four evaluated endpoints.

Apply the NIOSH decision rule to assign the overall final Occupational Exposure Band (OEB) for this chemical vapor.

State the target airborne concentration range in parts per million (ppm) for industrial hygiene control verification.

Solution Steps:

Evaluate Individual Health Endpoints against NIOSH OEB Criteria:

Inhalation Acute Toxicity (Vapor LC50 = 4.5 mg/L / Cat 3): Corresponds to Band C (> 1 to 10 ppm).

Skin Sensitization (Strong Sensitizer / Cat 1A): Corresponds to Band D (> 0.1 to 1 ppm).

Respiratory Sensitization (Category 1A): Severe, irreversible immune-mediated airway hyperreactivity corresponds to Band E (≤ 0.1 ppm, or < 0.001 ppm for extreme sensitizers).

Eye Irritation (Category 2A): Reversible irritation corresponds to Band B (> 10 to 100 ppm).

Apply the "Most Protective Band" Rule:

Comparing the individual bands: Band C, Band D, Band E, Band B.

The most stringent, health-protective band among all evaluated endpoints is Band E (driven by Respiratory Sensitization Category 1A).

Final Band Assignment: Band E .

Target Airborne Concentration Range:

For chemical vapors in Band E , the target airborne occupational exposure limit is ≤ 0.1 ppm (and down to < 0.001 ppm for potent sensitizers).

Engineering controls must incorporate high-containment gloveboxes or closed automated transfer systems to ensure airborne levels do not exceed 0.1 ppm.